Atlas Trials

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Clinical trial NCT02439203 · COMPLETED

Trial details

NCT number
NCT02439203
Sponsor
Bukwang Pharmaceutical
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's DiseaseLevodopa Induced Dyskinesia (LID)
Start date
2015-05-01
Primary completion
2015-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.